REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,055,445 | -15.6% | 3,867,610 | -18.5% | 0.01% | -14.3% |
Q2 2023 | $126,908,661 | +21.8% | 4,744,249 | -1.4% | 0.01% | +16.7% |
Q1 2023 | $104,215,595 | -42.1% | 4,811,431 | -36.4% | 0.01% | +20.0% |
Q4 2022 | $180,127,364 | +111.8% | 7,562,022 | +75.4% | 0.01% | 0.0% |
Q3 2022 | $85,035,000 | +41.0% | 4,312,134 | +39.3% | 0.01% | +25.0% |
Q2 2022 | $60,321,000 | -16.8% | 3,094,982 | +8.8% | 0.00% | 0.0% |
Q1 2022 | $72,537,000 | +4.6% | 2,843,477 | +3.2% | 0.00% | +33.3% |
Q4 2021 | $69,334,000 | -10.3% | 2,754,633 | -1.9% | 0.00% | -25.0% |
Q3 2021 | $77,280,000 | +3.7% | 2,809,172 | +19.6% | 0.00% | 0.0% |
Q2 2021 | $74,544,000 | -8.6% | 2,348,590 | +32.1% | 0.00% | -20.0% |
Q1 2021 | $81,583,000 | +15.0% | 1,778,180 | -0.7% | 0.01% | +25.0% |
Q4 2020 | $70,911,000 | +90.3% | 1,791,132 | +67.3% | 0.00% | +33.3% |
Q3 2020 | $37,267,000 | +350.1% | 1,070,902 | +308.3% | 0.00% | +200.0% |
Q2 2020 | $8,280,000 | +59.8% | 262,289 | +10.9% | 0.00% | – |
Q1 2020 | $5,181,000 | – | 236,451 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |